Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma – Mini-Review

MARIAN LIBERKO, KATARINA KOLOSTOVA, ARPAD SZABO, ROBERT GURLICH, MARTIN OLIVERIUS and RENATA SOUMAROVA
In Vivo January 2021, 35 (1) 31-39; DOI: https://doi.org/10.21873/invivo.12229
MARIAN LIBERKO
1Department of Radiotherapy and Oncology, University Hospital Kralovske Vinohorady, Prague, Czech Republic;
2Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marian.liberko{at}fnkv.cz
KATARINA KOLOSTOVA
3Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARPAD SZABO
4Department of Pathology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT GURLICH
5Department of General Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN OLIVERIUS
5Department of General Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RENATA SOUMAROVA
1Department of Radiotherapy and Oncology, University Hospital Kralovske Vinohorady, Prague, Czech Republic;
2Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 1 31-39
DOI 
https://doi.org/10.21873/invivo.12229
PMID 
33402447

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received October 29, 2020
  • Revision received November 19, 2020
  • Accepted November 21, 2020
  • Published online January 5, 2021.

Copyright & License 
Copyright © 2021 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MARIAN LIBERKO1,2⇑,
  2. KATARINA KOLOSTOVA3,
  3. ARPAD SZABO4,
  4. ROBERT GURLICH5,
  5. MARTIN OLIVERIUS5 and
  6. RENATA SOUMAROVA1,2
  1. 1Department of Radiotherapy and Oncology, University Hospital Kralovske Vinohorady, Prague, Czech Republic;
  2. 2Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  3. 3Department of Laboratory Genetics, Laboratory Diagnostics, University Hospital Kralovske Vinohrady, Prague, Czech Republic;
  4. 4Department of Pathology, Third Faculty of Medicine, Charles University in Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic;
  5. 5Department of General Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
  1. Correspondence to: Marian Liberko, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. E-mail: marian.liberko{at}fnkv.cz
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 35, Issue 1
January-February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma – Mini-Review
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma – Mini-Review
MARIAN LIBERKO, KATARINA KOLOSTOVA, ARPAD SZABO, ROBERT GURLICH, MARTIN OLIVERIUS, RENATA SOUMAROVA
In Vivo Jan 2021, 35 (1) 31-39; DOI: 10.21873/invivo.12229

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma – Mini-Review
MARIAN LIBERKO, KATARINA KOLOSTOVA, ARPAD SZABO, ROBERT GURLICH, MARTIN OLIVERIUS, RENATA SOUMAROVA
In Vivo Jan 2021, 35 (1) 31-39; DOI: 10.21873/invivo.12229
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Search Strategy and Selection Criteria
    • Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma
    • Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma
    • Other Prognostic and Predictive Markers in Pancreatic Ductal Adenocarcinoma
    • Systemic Inflammatory Response Index (SIRI)
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Research Progress on the Microregulatory Mechanisms of Fertilization: A Review
  • Gastric Cancer Invading the Pancreas: A Review of the Role of Pancreatectomy
  • Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review
Show more Reviews

Keywords

  • Pancreatic carcinoma
  • circulating tumor cells (CTC)
  • circulating tumor DNA (ctDNA)
  • prognostic index/score
  • liquid biopsy
  • biomarkers
  • review
In Vivo

© 2026 In Vivo

Powered by HighWire